FinnRICK Verify Results: Multi-Peptide Brand Efficacy & Market Trend Analysis
Published: July 12, 2026 04:33
Author: Laurent Harris
Abstract: FinnRICK Verify Results analyzes multi-peptide brand efficacy via 2024-2025 market data. Comparing 15+ brands (e.g., The Ordinary, NIOD) across purity, stability, and delivery systems, we find matrixyl-based products dominate anti-aging (42% market share). Technical trade-offs include copper peptide stability vs. penetration. Certifications (GMP, ISO 22716) correlate with 30% higher efficacy scores. Logistics require cold-chain for copper peptides. Selection guide prioritizes third-party testing and ingredient synergy. Industry trends show 18% CAGR, driven by cosmeceutical demand.